• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地高辛在一种新型胶囊可溶性药物制剂中的生物利用度。

Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules.

作者信息

Ghirardi P, Catenazzo G, Mantero O, Merotti G C, Marzo A

出版信息

J Pharm Sci. 1977 Feb;66(2):267-9. doi: 10.1002/jps.2600660233.

DOI:10.1002/jps.2600660233
PMID:839426
Abstract

The in vitro dissolution and the bioavailability of two pharmaceutical formulations of digoxin were compared, one being a common commercial tablet form and the other a solution of the glycoside in soft gelatin capsules. Digoxin capsules dissolved more readily in vitro and showed higher bioavailability than digoxin tablets in both dogs and humans. In dogs, the capsules and tablets were compared with an elixir of digoxin, which possesses complete bioavailability. The better bioavailability of digoxin capsules as compared with tablets may be explained by the fact that this formulation contains the cardiac glycoside in a solution.

摘要

比较了地高辛两种药物制剂的体外溶出度和生物利用度,一种是常见的市售片剂形式,另一种是糖苷在软胶囊中的溶液。地高辛胶囊在体外更容易溶解,并且在犬和人类中均显示出比地高辛片剂更高的生物利用度。在犬中,将胶囊和片剂与具有完全生物利用度的地高辛酏剂进行了比较。与片剂相比,地高辛胶囊具有更好的生物利用度,这可能是因为该制剂中的心苷处于溶液状态。

相似文献

1
Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules.地高辛在一种新型胶囊可溶性药物制剂中的生物利用度。
J Pharm Sci. 1977 Feb;66(2):267-9. doi: 10.1002/jps.2600660233.
2
Superior bioavailability of digoxin solution in capsules.
Clin Pharmacol Ther. 1975 Dec;18(6):761-8. doi: 10.1002/cpt1975186761.
3
An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin.
Arzneimittelforschung. 1979;29(7):1047-50.
4
Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients.
J Pharm Sci. 1979 Jan;68(1):104-6. doi: 10.1002/jps.2600680135.
5
Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
J Pharm Sci. 1977 May;66(5):644-7. doi: 10.1002/jps.2600660510.
6
A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.口服地高辛胶囊、片剂和溶液与静脉注射地高辛的生物利用度比较。
J Clin Pharmacol. 1976 Oct;16(10 Pt 1):461-7.
7
Greater bioavailability of digoxin solution in capsules. Studies in the postprandial state.
Clin Pharmacol Ther. 1977 Mar;21(3):278-82. doi: 10.1002/cpt1977213278.
8
Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets.
JAMA. 1974 Sep 23;229(13):1774-6.
9
[Biologic availability of digoxin in soft gelatin capsules and in tablets].
Boll Soc Ital Biol Sper. 1974 Oct 15;50(19):1612-4.
10
[Bioavailability of a solution of digoxin in a soft gelatin capsule].
Boll Soc Ital Cardiol. 1976;21(10):1781-5.

引用本文的文献

1
Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.
J Pharmacokinet Biopharm. 1979 Apr;7(2):147-58. doi: 10.1007/BF01059735.
2
Clinical pharmacokinetics of digoxin 1980.地高辛的临床药代动力学 1980 年
Clin Pharmacokinet. 1980 Mar-Apr;5(2):137-49. doi: 10.2165/00003088-198005020-00002.